找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Hypertension and Hormone Mechanisms; Robert M. Carey (David A. Harrison III Distinguish Book 2007 Humana Press 2007 Angiotensin II.aldoste

[復制鏈接]
樓主: 監(jiān)督
21#
發(fā)表于 2025-3-25 06:16:13 | 只看該作者
22#
發(fā)表于 2025-3-25 09:37:49 | 只看該作者
23#
發(fā)表于 2025-3-25 12:09:44 | 只看該作者
24#
發(fā)表于 2025-3-25 19:37:11 | 只看該作者
oupling. By its emphasis on biophysical aspects of a prevalent clinical condition, the monograph is unique in its perspective and focus. The breadth of information in the chapters all in one place will be of value to clinicians and researchers at all levels. Modern research approaches and clinical u
25#
發(fā)表于 2025-3-25 20:26:40 | 只看該作者
Ernesto L. Schiffrin MD, PhD, FRCPCoupling. By its emphasis on biophysical aspects of a prevalent clinical condition, the monograph is unique in its perspective and focus. The breadth of information in the chapters all in one place will be of value to clinicians and researchers at all levels. Modern research approaches and clinical u
26#
發(fā)表于 2025-3-26 03:53:15 | 只看該作者
Cardiac and Vascular Renin-Angiotensin Systemsype 1 plasma membrane (AT.) receptor. The AT1 is a seven-transmembrane spanning, heterotrimeric G protein-coupled receptor (GPCR) that activates multiple signal transduction pathways. An AT. receptor, which in large part couples to effector pathways that antagonize the AT. effects, is also present i
27#
發(fā)表于 2025-3-26 07:10:27 | 只看該作者
Insulin Resistance and Hypertensione blood pressure, the greater the chance of myocardial infarction, heart failure, stroke, and renal disease. The CVD risk escalates further when other risk factors are present, as in patients with metabolic syndrome.
28#
發(fā)表于 2025-3-26 08:58:50 | 只看該作者
Book 2007ted areas of diagnosis and therapy...With a focus on new developments in hormones and autacoids related to hypertension, Hypertension and Hormone Mechanisms provides a resource that will lead to new, active research in the fundamental mechanisms of hypertension..
29#
發(fā)表于 2025-3-26 14:44:48 | 只看該作者
Angiotensin IV Binding Site.). This binding site was termed as the angiotensin AT. receptor by an IUPHAR nomenclature committee (.). This AT. receptor site is pharmacologically distinct from both Ang II AT. and AT. receptors, and bound Ang II at only micromolar affinity.
30#
發(fā)表于 2025-3-26 18:55:24 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 15:27
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
甘谷县| 白水县| 吉安市| 玉树县| 西安市| 长葛市| 晴隆县| 昌都县| 新巴尔虎左旗| 惠东县| 含山县| 云阳县| 和平县| 樟树市| 陵水| 镇坪县| 天水市| 兰溪市| 元谋县| 大埔县| 宣汉县| 大埔区| 出国| 苏尼特左旗| 太白县| 桃源县| 新乡县| 平遥县| 石首市| 土默特左旗| 景泰县| 自治县| 临海市| 南丹县| 肃北| 海林市| 高唐县| 阳新县| 福贡县| 乐至县| 阳山县|